Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Senomyx Sets Fourth Quarter and Fiscal Year 2017 Earnings Call for Thursday, March 8, 2018 at 5:00 p.m. ET

Posted on: 28 Feb 18

SAN DIEGO, Feb. 27, 2018 /PRNewswire/ -- Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners, will hold a conference call on Thursday, March 8, 2018 at 5:00 p.m. Eastern time to discuss its financial results for the fourth quarter and full year ended December 31, 2017. Financial results will be issued in a press release prior to the call.

Senomyx management will host the conference call, followed by a question and answer period.

Date: Thursday, March 8, 2018
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
U.S. dial-in number: 844-825-0514
International number: 315-625-6892
Conference ID: 2684448

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 949-574-3860.   

The conference call will be broadcast live and available for replay here and via the investor relations section of the company's website.

About Senomyx, Inc. 
Senomyx discovers novel flavor ingredients and natural high intensity sweeteners that allow food and beverage companies to create better-for-you products. Under its direct sales program, Senomyx sells its Complimyx® brand flavor ingredients, Sweetmyx®, Savorymyx®, and Bittermyx®, to flavor companies for use in a wide variety of foods and beverages. In addition, Senomyx has partnerships with leading global food, beverage, and ingredient supply companies, which are currently marketing products that contain Senomyx's flavor ingredients. For more information, please visit

Company Contact:
Dave Humphrey
Vice President, Finance
Senomyx, Inc.

Investor Relations:
Matt Glover and Tom Colton
Liolios Group, Inc.

Editor's Details

Mike Wood

Last updated on: 28/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.